Naturally Occurring Anthraquinones: Chemistry and Therapeutic Potential in Autoimmune Diabetes

被引:80
作者
Chien, Shih-Chang [1 ]
Wu, Yueh-Chen [2 ]
Chen, Zeng-Weng [3 ]
Yang, Wen-Chin [2 ,3 ,4 ,5 ,6 ,7 ]
机构
[1] Natl Chung Hsing Univ, Dept Forestry, Taichung 402, Taiwan
[2] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan
[3] Anim Technol Inst, Chunan 350, Taiwan
[4] Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan
[5] Natl Taiwan Univ, Inst Biotechnol, Taipei 106, Taiwan
[6] Natl Taiwan Ocean Univ, Dept Aquaculture, Keelung 202, Taiwan
[7] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan
关键词
CHEMOKINE RECEPTORS; POLYGONUM-CUSPIDATUM; BETA-CELL; KINASE INHIBITORS; CCR5; RECEPTOR; EMODIN; ATTRACTION; ROOTS; CONSTITUENTS; INFLAMMATION;
D O I
10.1155/2015/357357
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Anthraquinones are a class of aromatic compounds with a 9,10-dioxoanthracene core. So far, 79 naturally occurring anthraquinones have been identified which include emodin, physcion, cascarin, catenarin, and rhein. A large body of literature has demonstrated that the naturally occurring anthraquinones possess a broad spectrum of bioactivities, such as cathartic, anticancer, anti-inflammatory, antimicrobial, diuretic, vasorelaxing, and phytoestrogen activities, suggesting their possible clinical application in many diseases. Despite the advances that have been made in understanding the chemistry and biology of the anthraquinones in recent years, research into their mechanisms of action and therapeutic potential in autoimmune disorders is still at an early stage. In this paper, we briefly introduce the etiology of autoimmune diabetes, an autoimmune disorder that affects as many as 10 million worldwide, and the role of chemotaxis in autoimmune diabetes. We then outline the chemical structure and biological properties of the naturally occurring anthraquinones and their derivatives with an emphasis on recent findings about their immune regulation. We discuss the structure and activity relationship, mode of action, and therapeutic potential of the anthraquinones in autoimmune diabetes, including a new strategy for the use of the anthraquinones in autoimmune diabetes.
引用
收藏
页数:13
相关论文
共 71 条
[1]   The CXCR4/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes [J].
Aboumrad, E. ;
Madec, A. M. ;
Thivolet, C. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 148 (03) :432-439
[2]   Chemokine: Receptor structure, interactions, and antagonism [J].
Allen, Samantha J. ;
Crown, Susan E. ;
Handel, Tracy M. .
ANNUAL REVIEW OF IMMUNOLOGY, 2007, 25 :787-820
[3]   Fatal attraction: chemokines, and type 1 diabetes [J].
Atkinson, MA ;
Wilson, SB .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (11) :1611-1613
[4]  
Bachmann M, 1992, J Environ Pathol Toxicol Oncol, V11, P49
[5]   INVESTIGATIONS ON DNA-BINDING IN RAT-LIVER AND IN SALMONELLA AND ON MUTAGENICITY IN THE AMES TEST BY EMODIN, A NATURAL ANTHRAQUINONE [J].
BOSCH, R ;
FRIEDERICH, U ;
LUTZ, WK ;
BROCKER, E ;
BACHMANN, M ;
SCHLATTER, C .
MUTATION RESEARCH, 1987, 188 (03) :161-168
[6]  
Bradley LM, 1999, J IMMUNOL, V162, P2511
[7]   Moving towards efficient therapies in type 1 diabetes: To combine or not to combine? [J].
Bresson, D. ;
von Herrath, M. .
AUTOIMMUNITY REVIEWS, 2007, 6 (05) :315-322
[8]   Orchestrating the orchestrators: chemokines in control of T cell traffic [J].
Bromley, Shannon K. ;
Mempel, Thorsten R. ;
Luster, Andrew D. .
NATURE IMMUNOLOGY, 2008, 9 (09) :970-980
[9]   Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes [J].
Cameron, MJ ;
Arreaza, GA ;
Grattan, M ;
Meagher, C ;
Sharif, S ;
Burdick, MD ;
Strieter, RM ;
Cook, DN ;
Delovitch, TL .
JOURNAL OF IMMUNOLOGY, 2000, 165 (02) :1102-1110
[10]   Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in nonobese diabetic mice [J].
Carvalho-Pinto, C ;
García, MI ;
Gómez, L ;
Ballesteros, A ;
Zaballos, A ;
Flores, JM ;
Mellado, M ;
Rodríguez-Frade, JM ;
Balomenos, D ;
Martinez, C .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (02) :548-557